Infertility Treatment Market

1.1. Global Market Outlook
1.2. Summary of Statistics
1.3. Key Market Characteristics & Attributes
1.4. Fact.MR Analysis and Recommendations

2.1. Market Coverage
2.2. Market Definition

3.1. Risk Assessment
3.1.1. COVID-19 Crisis and Impact on Infertility Treatment Demand
3.1.2. COVID-19 Impact Benchmark with Previous Crisis
3.1.3. Impact on Market Value (US$ Mn)
3.1.4. Assessment by Key Countries
3.1.5. Assessment by Key Market Segments
3.1.6. Action Points and Recommendation for Suppliers
3.2. Key Trends Impacting the Market
3.3. Formulation and Product Development Trends

4.1. Infertility Treatment Market, by Key Countries
4.2. Infertility Treatment Market Opportunity Assessment (US$ Mn)
4.2.1. Total Available Market
4.2.2. Serviceable Addressable Market
4.2.3. Serviceable Obtainable Market
4.3. Market Scenario Forecast
4.3.1. Demand in optimistic Scenario
4.3.2. Demand in Likely Scenario
4.3.3. Demand in Conservative Scenario
4.4. Investment Feasibility Analysis
4.4.1. Investment in Established Markets
4.4.1.1. In Short Term
4.4.1.2. In Long Term
4.4.2. Investment in Emerging Markets
4.4.2.1. In Short Term
4.4.2.2. In Long Term
4.5. Forecast Factors - Relevance & Impact
4.5.1. Top Companies Historical Growth
4.5.2. Growth in Automation, By Country
4.5.3. Infertility Treatment Adoption Rate, By Country
4.6. Market Dynamics
4.6.1. Market Driving Factors and Impact Assessment
4.6.2. Prominent Market Challenges and Impact Assessment
4.6.3. Infertility Treatment Market Opportunities
4.6.4. Prominent Trends in the Global Market & Their Impact Assessment

5.1. Manufacturers’ Focus on Low Penetration High Growth Markets
5.2. Banking on with Segments High Incremental Opportunity
5.3. Peer Benchmarking

6.1. Historical Market Analysis, 2015-2021
6.2. Current and Future Market Projections, 2022-2032
6.3. Y-o-Y Growth Trend Analysis

7.1. Historical Market Value (US$ Mn) Analysis, 2015-2021
7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis

8.1. Introduction/Key Findings
8.2. Historical Market Size (US$ Mn) Analysis By Product, 2015-2021
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product, 2022-2032
8.3.1. Equipment
8.3.1.1. Microscopes
8.3.1.2. Imaging Systems
8.3.1.3. Sperm Analyzer Systems
8.3.1.4. Ovum Aspiration Pumps
8.3.1.5. Micromanipulator Systems
8.3.1.6. Incubators
8.3.1.7. Gas Analyzers
8.3.1.8. Laser Systems
8.3.1.9. Cryosystems
8.3.1.10. Sperm Separation Devices
8.3.2. Media & Consumables
8.3.3. Accessories
8.4. Market Attractiveness Analysis By Product

9.1. Introduction/Key Findings
9.2. Historical Market Size (US$ Mn) Analysis By Procedure, 2015-2021
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Procedure, 2022-2032
9.3.1. Assisted Reproductive Technology
9.3.1.1. In Vitro Fertilization
9.3.1.1.1. Intracytoplasmic Morphologically Selected Sperm Injection
9.3.1.1.2. Gamete Donation
9.3.1.2. Intracytoplasmic Sperm Injection
9.3.1.3. Surrogacy
9.3.2. Artificial Insemination
9.3.2.1. Intrauterine Insemination
9.3.2.2. Intracervical Insemination
9.3.2.3. Intratubal Insemination
9.3.3. Fertility Surgeries
9.3.3.1. Laparoscopy
9.3.3.2. Hysteroscopy
9.3.3.3. Varicocelectomy
9.3.3.4. Laparotomy
9.3.3.5. Tubal Ligation Reversal
9.3.3.6. Varicocelectomy
9.3.3.7. Microsurgical Reconstruction
9.3.3.7.1. Vasovasostomy
9.3.3.7.2. Vasoepididymostomy
9.3.4. Other Infertility Treatment Procedures
9.4. Market Attractiveness Analysis By Procedure

10.1. Introduction/Key Findings
10.2. Historical Market Size (US$ Mn) Analysis By Patient type, 2015-2021
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Patient type, 2022-2032
10.3.1. Female Infertility Treatment
10.3.2. Male Infertility Treatment
10.4. Market Attractiveness Analysis By Patient type

11.1. Introduction/Key Findings
11.2. Historical Market Size (US$ Mn) Analysis By End User, 2015-2021
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2022-2032
11.3.1. Fertility Centers
11.3.2. Hospitals & Surgical Clinics
11.3.3. Cryobanks
11.3.4. Research Institutes
11.4. Market Attractiveness Analysis By End User

12.1. Introduction
12.2. Historical Market Size (US$ Mn) Analysis By Region, 2015-2021
12.3. Current Market Size (US$ Mn) & Analysis and Forecast By Region, 2022-2032
12.3.1. North America
12.3.2. Latin America
12.3.3. Europe
12.3.4. Asia Pacific
12.3.5. Middle East and Africa (MEA)
12.4. Market Attractiveness Analysis By Region

13.1. Introduction
13.2. Pricing Analysis
13.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
13.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
13.4.1. By Country
13.4.1.1. U.S.
13.4.1.2. Canada
13.4.1.3. Rest of North America
13.4.2. By Product
13.4.3. By Procedure
13.4.4. By End User
13.4.5. By Patient type
13.5. Market Attractiveness Analysis
13.5.1. By Country
13.5.2. By Product
13.5.3. By Procedure
13.5.4. By End User
13.5.5. By Patient type

14.1. Introduction
14.2. Pricing Analysis
14.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
14.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
14.4.1. By Country
14.4.1.1. Brazil
14.4.1.2. Mexico
14.4.1.3. Rest of Latin America
14.4.2. By Product
14.4.3. By Procedure
14.4.4. By End User
14.4.5. By Patient type
14.5. Market Attractiveness Analysis
14.5.1. By Country
14.5.2. By Product
14.5.3. By Procedure
14.5.4. By End User
14.5.5. By Patient type

15.1. Introduction
15.2. Pricing Analysis
15.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
15.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
15.4.1. By Country
15.4.1.1. Germany
15.4.1.2. France
15.4.1.3. U.K.
15.4.1.4. Italy
15.4.1.5. Benelux
15.4.1.6. Nordic Countries
15.4.1.7. Rest of Europe
15.4.2. By Product
15.4.3. By Procedure
15.4.4. By End User
15.4.5. By Patient type
15.5. Market Attractiveness Analysis
15.5.1. By Country
15.5.2. By Product
15.5.3. By Procedure
15.5.4. By End User
15.5.5. By Patient type

16.1. Introduction
16.2. Pricing Analysis
16.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
16.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
16.4.1. By Country
16.4.1.1. China
16.4.1.2. Japan
16.4.1.3. South Korea
16.4.1.4. Rest of Asia Pacific
16.4.2. By Product
16.4.3. By Procedure
16.4.4. By End User
16.4.5. By Patient type
16.5. Market Attractiveness Analysis
16.5.1. By Country
16.5.2. By Product
16.5.3. By Procedure
16.5.4. By End User
16.5.5. By Patient type

17.1. Introduction
17.2. Pricing Analysis
17.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
17.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
17.4.1. By Country
17.4.1.1. GCC Countries
17.4.1.2. South Africa
17.4.1.3. Turkey
17.4.1.4. Rest of Middle East and Africa
17.4.2. By Product
17.4.3. By Procedure
17.4.4. By End User
17.4.5. By Patient type
17.5. Market Attractiveness Analysis
17.5.1. By Country
17.5.2. By Product
17.5.3. By Procedure
17.5.4. By End User
17.5.5. By Patient type

18.1. Introduction
18.1.1. Market Value Proportion Analysis, By Key Countries
18.1.2. Global Vs. Country Growth Comparison
18.2. US Infertility Treatment Market Analysis
18.2.1. Value Proportion Analysis by Market Taxonomy
18.2.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032
18.2.2.1. By Product
18.2.2.2. By Procedure
18.2.2.3. By End User
18.2.2.4. By Patient type
18.3. Canada Infertility Treatment Market Analysis
18.3.1. Value Proportion Analysis by Market Taxonomy
18.3.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032
18.3.2.1. By Product
18.3.2.2. By Procedure
18.3.2.3. By End User
18.3.2.4. By Patient type
18.4. Mexico Infertility Treatment Market Analysis
18.4.1. Value Proportion Analysis by Market Taxonomy
18.4.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032
18.4.2.1. By Product
18.4.2.2. By Procedure
18.4.2.3. By End User
18.4.2.4. By Patient type
18.5. Brazil Infertility Treatment Market Analysis
18.5.1. Value Proportion Analysis by Market Taxonomy
18.5.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032
18.5.2.1. By Product
18.5.2.2. By Procedure
18.5.2.3. By End User
18.5.2.4. By Patient type
18.6. Germany Infertility Treatment Market Analysis
18.6.1. Value Proportion Analysis by Market Taxonomy
18.6.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032
18.6.2.1. By Product
18.6.2.2. By Procedure
18.6.2.3. By End User
18.6.2.4. By Patient type
18.7. France Infertility Treatment Market Analysis
18.7.1. Value Proportion Analysis by Market Taxonomy
18.7.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032
18.7.2.1. By Product
18.7.2.2. By Procedure
18.7.2.3. By End User
18.7.2.4. By Patient type
18.8. Italy Infertility Treatment Market Analysis
18.8.1. Value Proportion Analysis by Market Taxonomy
18.8.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032
18.8.2.1. By Product
18.8.2.2. By Procedure
18.8.2.3. By End User
18.8.2.4. By Patient type
18.9. BENELUX Infertility Treatment Market Analysis
18.9.1. Value Proportion Analysis by Market Taxonomy
18.9.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032
18.9.2.1. By Product
18.9.2.2. By Procedure
18.9.2.3. By End User
18.9.2.4. By Patient type
18.10. UK Infertility Treatment Market Analysis
18.10.1. Value Proportion Analysis by Market Taxonomy
18.10.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032
18.10.2.1. By Product
18.10.2.2. By Procedure
18.10.2.3. By End User
18.10.2.4. By Patient type
18.11. Nordic Countries Infertility Treatment Market Analysis
18.11.1. Value Proportion Analysis by Market Taxonomy
18.11.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032
18.11.2.1. By Product
18.11.2.2. By Procedure
18.11.2.3. By End User
18.11.2.4. By Patient type
18.12. China Infertility Treatment Market Analysis
18.12.1. Value Proportion Analysis by Market Taxonomy
18.12.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032
18.12.2.1. By Product
18.12.2.2. By Procedure
18.12.2.3. By End User
18.12.2.4. By Patient type
18.13. Japan Infertility Treatment Market Analysis
18.13.1. Value Proportion Analysis by Market Taxonomy
18.13.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032
18.13.2.1. By Product
18.13.2.2. By Procedure
18.13.2.3. By End User
18.13.2.4. By Patient type
18.14. South Korea Infertility Treatment Market Analysis
18.14.1. Value Proportion Analysis by Market Taxonomy
18.14.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032
18.14.2.1. By Product
18.14.2.2. By Procedure
18.14.2.3. By End User
18.14.2.4. By Patient type
18.15. GCC Countries Infertility Treatment Market Analysis
18.15.1. Value Proportion Analysis by Market Taxonomy
18.15.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032
18.15.2.1. By Product
18.15.2.2. By Procedure
18.15.2.3. By End User
18.15.2.4. By Patient type
18.16. South Africa Infertility Treatment Market Analysis
18.16.1. Value Proportion Analysis by Market Taxonomy
18.16.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032
18.16.2.1. By Product
18.16.2.2. By Procedure
18.16.2.3. By End User
18.16.2.4. By Patient type
18.17. Turkey Infertility Treatment Market Analysis
18.17.1. Value Proportion Analysis by Market Taxonomy
18.17.2. Value Analysis and Forecast by Market Taxonomy, 2015-2032
18.17.2.1. By Product
18.17.2.2. By Procedure
18.17.2.3. By End User
18.17.2.4. By Patient type
18.17.3. Competition Landscape and Player Concentration in the Country

19.1. Market Analysis by Tier of Companies
19.2. Market Concentration
19.3. Market Share Analysis of Top Players
19.4. Market Presence Analysis
19.4.1. By Regional footprint of Players
19.4.2. Product footprint by Players

20.1. Competition Dashboard
20.2. Competition Benchmarking
20.3. Competition Deep Dive
20.3.1. The Cooper Companies, Inc.
20.3.1.1. Overview
20.3.1.2. Product Portfolio
20.3.1.3. Sales Footprint
20.3.1.4. Strategy Overview
20.3.2. Cook Group
20.3.2.1. Overview
20.3.2.2. Product Portfolio
20.3.2.3. Sales Footprint
20.3.2.4. Strategy Overview
20.3.3. Vitrolife
20.3.3.1. Overview
20.3.3.2. Product Portfolio
20.3.3.3. Sales Footprint
20.3.3.4. Strategy Overview
20.3.4. Thermo Fisher Scientific
20.3.4.1. Overview
20.3.4.2. Product Portfolio
20.3.4.3. Sales Footprint
20.3.4.4. Strategy Overview
20.3.5. Hamilton Thorne LTD
20.3.5.1. Overview
20.3.5.2. Product Portfolio
20.3.5.3. Sales Footprint
20.3.5.4. Strategy Overview
20.3.6. Esco Micro Pte Ltd
20.3.6.1. Overview
20.3.6.2. Product Portfolio
20.3.6.3. Sales Footprint
20.3.6.4. Strategy Overview
20.3.7. Genea Limited
20.3.7.1. Overview
20.3.7.2. Product Portfolio
20.3.7.3. Sales Footprint
20.3.7.4. Strategy Overview
20.3.8. IVFtech APS
20.3.8.1. Overview
20.3.8.2. Product Portfolio
20.3.8.3. Sales Footprint
20.3.8.4. Strategy Overview
20.3.9. FUJIFILM Irvine Scientific
20.3.9.1. Overview
20.3.9.2. Product Portfolio
20.3.9.3. Sales Footprint
20.3.9.4. Strategy Overview
20.3.10. The Baker Company INC
20.3.10.1. Overview
20.3.10.2. Product Portfolio
20.3.10.3. Sales Footprint
20.3.10.4. Strategy Overview